Viewing a single comment thread. View all comments

Trash_Panda-1 t1_j68wk1r wrote on January 28, 2023 at 4:17 PM

Reply to comment by Trash_Panda-1 in Abbvie to lose most lucrative patent protection one week before Q4 earnings call. by [deleted]

https://www.biostock.se/en/2022/12/several-blockbuster-patents-to-expire-in-2023/#:~:text=The%20main%20patent%20for%20Humira,product%20well%20into%20the%20future.

Here is a non-paywall article. It also mentions that Humira accounted for 43% of Abbvie's sales last year.